Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.56
+0.78 (16.32%)
At close: Jun 6, 2025, 4:00 PM
5.58
+0.02 (0.36%)
After-hours: Jun 6, 2025, 7:17 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Therapeutics for the Treatment of Metabolic Dysfunction-associated Steatohepatitis and Other Diseases
2.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
2.00M